Taken together, these results hint that CD4 CAR-T cells are crucial players in CRS development and that CD28 co-stimulation is associated with an increased toxic potential when dealing with the CD4 T-cell lineage. This evidence concerns the gene CD28 and congenital rubella syndrome.